✦ LIBER ✦
Treatment of patients with KRAS wild type advanced colorectal cancer with 5-fluorouracil (5-FU) or 5-FU plus an epidermal growth factor receptor inhibitor (cetuximab) based on a comprehensive geriatric assessment
✍ Scribed by Wedding, U.; Messina, C.; Mauer, M.; Pallis, A.; Harrison, J.; Wildiers, H.; Peeters, M.
- Book ID
- 122220947
- Publisher
- Elsevier
- Year
- 2013
- Tongue
- English
- Weight
- 50 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1879-4068
No coin nor oath required. For personal study only.